Deep melodic house as a multi-domain non-pharmacological wellbeing intervention. A clinical synthesis of music neuroscience evidence, organised into a four-pathway model with applications across eight clinical domains.
The framework explains how a specific acoustic signature drives measurable change through autonomic, neuroendocrine, cognitive-affective and socio-behavioural pathways. Each is grounded in the music neuroscience literature and explicitly linked to clinical outcome.
Belonging, identity, ritual, healthy substitution behaviour. Particularly relevant to recovery.
StressAnxietyDepressionSleepADHDCardiovascularPainMenstrual and menopausalAddiction recovery
The genre, in pictures
The music in its cultural context
Translating evidence into clinical practice means understanding what the music actually feels like, who plays it, and where it lives. The full report includes a visual essay grounding the academic framework in lived reality.
The evidence
Effect sizes that compare favourably with first-line interventions
Drawn from meta-analyses where available and individual high-quality trials otherwise. Effects are typically small to medium for stand-alone music interventions, growing larger when combined with movement, mindfulness or cognitive elements.
d = 0.72
Music therapy on stress reduction (de Witte 2020 meta-analysis)
PSQI -3.4
Sleep quality improvement in older adults (He 2026)
SMD 0.50
Inhibitory control gains in ADHD populations (Song 2023)
-41%
HAMD-17 depression score reduction at eight weeks (Han 2026)
Read it in full
An evidence-grounded clinical model, now ready to use
The full report covers the acoustic signature, four pathways in mechanistic detail, eight clinical domains with effect sizes, a five-tier implementation pathway from self-directed listening through to AI-driven adaptive systems, and a research agenda. The screening tool maps individual symptoms to a specific listening profile in five minutes.
